Connect Biopharma Holdings Limited CNTB
0.78 USD +0.01 (+0.97%)
Nov 4, 2026, 1:24 PM EST
0.77 Day range 0.8149
0.732 52-week range 3.82
- YTD
- -72.28%
- 1 year
- -53.48%
Analyst view
Price target (mean) 7.00 +795.6% upside
Now 0.7816
- Target (low)
- 6.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | -0.20 | -0.20 – -0.20 | -1.08 | +81.5% | 170.93M | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.20 | +100.0% | 280.15M | +63.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 17, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 4, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 13, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Feb 8, 2023 | SVB Leerink | Maintained | — | Outperform |
| Jun 2, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 5, 2022 | Piper Sandler | Downgrade | Overweight | Neutral |
| May 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jan 6, 2022 | SVB Leerink | Maintained | — | Outperform |
| Apr 13, 2021 | Jefferies | Initiated | — | Buy |
| Apr 13, 2021 | SVB Leerink | Initiated | — | Outperform |